4-6 Nov 2019
& 13-15 May 2020 , 11-13 Nov 2020
GBP 1,799 1,499 *
EUR 2,519 2,099 *
USD 2,806 2,338 *
* When you book before 23 Aug
Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This course has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.
The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with the pharmaceutical case studies from business schools.
Pharmaceutical industry context – business school pharmaceutical case studies on each module
This intensive course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biotech/ generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.
The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees within the industry to focus on successful leadership and business management skills, which this programme is designed to give you.
The skills you will improve include:
Residential option available to include 2 nights bed & breakfast – select at checkout.
MBA learning style of the programme
The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. This intensive three-day course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-course work set by the programme director.
A ‘must-attend’ for professionals in the pharmaceutical/ biotech/medical device industries wishing to develop their business management skills for more senior levels and beyond mere technical skills. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.
Introduction, welcome and key objectives of the course
Commercial management and leadership in the pharma industry
- What are the core competencies of effective leaders in pharma?
- Leadership vs management
- Leadership style and approaches in the pharma industry
Leading and implementing pharma strategy and change
Leading successful change
- Diagnosis around change
- How to create the conditions for successful change
- Why people resist change and how to manage this
- Change management including leading a structural reorganisation
- Creating a team, department and organisation relevant to today’s pharma business needs
- Team formation and development
Implementing strategy and change, essentials of planning and managing projects
- Project management tools and techniques to use in implementing pharma projects
- Applying key project management techniques to pharma projects
- Understanding of cultural awareness to work more effectively with pharma colleagues
Hot topics in market access strategy
Laura Brown (4-6 Nov 2019, 13-15 May 2020, 11-13 Nov 2020)
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.
Nick Meadows (4-6 Nov 2019)
Nick Meadows has nearly 10 years of experience working in the life sciences industry as a management consultant, technology transfer analyst and medical research scientist. In 2016 he joined Strategy& (part of the PwC network) where he is supporting clients within the pharmaceutical industry address strategic and operational challenges in development and commercial functions.
As a consultant he has managed engagements across research and development and commercial functions of the life sciences and pharmaceutical industry. In the past 5 years his work has spanned major transformational projects in clinical operations and research and development, to asset level strategy through direct engagement with program teams and commercial leads. In his former role at Kinapse (2011 – 2016) he led the market access service line where he supported clients optimise pricing and reimbursement outcomes for launching and development products.
In addition he has collaborated with regulators, policy makers and healthcare practitioners to provide recommendations to accelerate the development of personalised medicines. He has also developed a deep understanding of the biosimilars landscape.
He holds an MBA from Saïd Business School, University of Oxford, and a PhD and BSc (Hons) in Molecular Biology from University of Queensland, Brisbane, Australia.
|4-6 Nov 2019|
|4-6 Nov 2019||Rembrandt Hotel, London||GBP 1,799.00
+ VAT @ 20.00%
Until 23 Aug*
|13-15 May 2020|
|13-15 May 2020||Rembrandt Hotel, London||GBP 1,799.00
+ VAT @ 20.00%
|Online registration unavailable: this date is nearing full capacity; please call us on 020 7749 4730 to register.|
|11-13 Nov 2020|
|11-13 Nov 2020||Venue not yet confirmed||
+ VAT @ 20.00%
* Note the early booking discount cannot be combined with any other offers or promotional code